These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38561942)

  • 1. Epitranscriptomic orchestrations: Unveiling the regulatory paradigm of m6A, A-to-I editing, and m5C in breast cancer via long noncoding RNAs and microRNAs.
    Yin Q; Qu Z; Mathew R; Zeng L; Du Z; Xue Y; Liu D; Zheng X
    Cell Biochem Funct; 2024 Apr; 42(3):e3996. PubMed ID: 38561942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
    Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
    Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epitranscriptome of long noncoding RNAs in metabolic diseases.
    Yin L; Zhu X; Novák P; Zhou L; Gao L; Yang M; Zhao G; Yin K
    Clin Chim Acta; 2021 Apr; 515():80-89. PubMed ID: 33422492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.
    Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoding RNAs in breast cancer.
    Lo PK; Wolfson B; Zhou X; Duru N; Gernapudi R; Zhou Q
    Brief Funct Genomics; 2016 May; 15(3):200-21. PubMed ID: 26685283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review.
    Saadh MJ; Allela OQB; Sattay ZJ; Al Zuhairi RAH; Ahmad H; Eldesoky GE; Adil M; Ali MS
    Pathol Res Pract; 2024 Mar; 255():155158. PubMed ID: 38320438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer.
    Abu-Alghayth MH; Khan FR; Belali TM; Abalkhail A; Alshaghdali K; Nassar SA; Almoammar NE; Almasoudi HH; Hessien KBG; Aldossari MS; Binshaya AS
    Pathol Res Pract; 2024 Mar; 255():155180. PubMed ID: 38330621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.
    Ashekyan O; Abdallah S; Shoukari AA; Chamandi G; Choubassy H; Itani ARS; Alwan N; Nasr R
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Breast Cancer Progression by Noncoding RNAs.
    Akshaya RL; Rohini M; Selvamurugan N
    Curr Cancer Drug Targets; 2020; 20(10):757-767. PubMed ID: 32652909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
    Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
    Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer.
    Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H
    Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma.
    Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H
    BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Expression of
    Rishehri M; Etemadi T; Pisheh L; Koufigar G; Azadeh M
    Genet Res (Camb); 2022; 2022():6787791. PubMed ID: 36160032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.
    Venkatesh J; Wasson MD; Brown JM; Fernando W; Marcato P
    Cancer Lett; 2021 Jul; 509():81-88. PubMed ID: 33848519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complex role of MEG3: An emerging long non-coding RNA in breast cancer.
    Hussain MS; Majami AA; Ali H; Gupta G; Almalki WH; Alzarea SI; Kazmi I; Syed RU; Khalifa NE; Bin Break MK; Khan R; Altwaijry N; Sharma R
    Pathol Res Pract; 2023 Nov; 251():154850. PubMed ID: 37839358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis.
    An M; Zang X; Wang J; Kang J; Tan X; Fu B
    Epigenomics; 2021 Jul; 13(14):1113-1128. PubMed ID: 34148372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression.
    Lv W; Tan Y; Xiong M; Zhao C; Wang Y; Wu M; Wu Y; Zhang Q
    J Transl Med; 2021 Dec; 19(1):527. PubMed ID: 34952600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs.
    Jacob R; Zander S; Gutschner T
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA FBXL19-AS1 promotes breast cancer cells proliferation and invasion via acting as a molecular sponge to miR-718.
    Ding Z; Ye P; Yang X; Cai H
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30886065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.